JP2009039107A5 - - Google Patents

Download PDF

Info

Publication number
JP2009039107A5
JP2009039107A5 JP2008184139A JP2008184139A JP2009039107A5 JP 2009039107 A5 JP2009039107 A5 JP 2009039107A5 JP 2008184139 A JP2008184139 A JP 2008184139A JP 2008184139 A JP2008184139 A JP 2008184139A JP 2009039107 A5 JP2009039107 A5 JP 2009039107A5
Authority
JP
Japan
Prior art keywords
sample
cancer
antibody
seq
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008184139A
Other languages
English (en)
Japanese (ja)
Other versions
JP4768783B2 (ja
JP2009039107A (ja
Filing date
Publication date
Priority claimed from US08/791,115 external-priority patent/US6262242B1/en
Application filed filed Critical
Publication of JP2009039107A publication Critical patent/JP2009039107A/ja
Publication of JP2009039107A5 publication Critical patent/JP2009039107A5/ja
Application granted granted Critical
Publication of JP4768783B2 publication Critical patent/JP4768783B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2008184139A 1997-01-30 2008-07-15 Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子 Expired - Lifetime JP4768783B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/791,115 1997-01-30
US08/791,115 US6262242B1 (en) 1997-01-30 1997-01-30 Tumor suppressor designated TS10Q23.3

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP53289798A Division JP2001511002A (ja) 1997-01-30 1998-01-08 Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010139230A Division JP5202583B2 (ja) 1997-01-30 2010-06-18 Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子

Publications (3)

Publication Number Publication Date
JP2009039107A JP2009039107A (ja) 2009-02-26
JP2009039107A5 true JP2009039107A5 (enExample) 2011-03-17
JP4768783B2 JP4768783B2 (ja) 2011-09-07

Family

ID=25152739

Family Applications (5)

Application Number Title Priority Date Filing Date
JP53289798A Withdrawn JP2001511002A (ja) 1997-01-30 1998-01-08 Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子
JP2008184139A Expired - Lifetime JP4768783B2 (ja) 1997-01-30 2008-07-15 Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子
JP2010139230A Expired - Lifetime JP5202583B2 (ja) 1997-01-30 2010-06-18 Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子
JP2013006918A Withdrawn JP2013128485A (ja) 1997-01-30 2013-01-18 Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子
JP2014040353A Withdrawn JP2014155493A (ja) 1997-01-30 2014-03-03 Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP53289798A Withdrawn JP2001511002A (ja) 1997-01-30 1998-01-08 Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2010139230A Expired - Lifetime JP5202583B2 (ja) 1997-01-30 2010-06-18 Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子
JP2013006918A Withdrawn JP2013128485A (ja) 1997-01-30 2013-01-18 Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子
JP2014040353A Withdrawn JP2014155493A (ja) 1997-01-30 2014-03-03 Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子

Country Status (14)

Country Link
US (1) US6262242B1 (enExample)
EP (2) EP2366712A3 (enExample)
JP (5) JP2001511002A (enExample)
AR (1) AR011607A1 (enExample)
AT (1) ATE499444T1 (enExample)
AU (1) AU745296B2 (enExample)
CA (1) CA2278849C (enExample)
DE (1) DE69842141D1 (enExample)
DK (1) DK0972024T4 (enExample)
ES (1) ES2361044T5 (enExample)
IL (1) IL131168A0 (enExample)
PT (1) PT972024E (enExample)
WO (1) WO1998033907A1 (enExample)
ZA (1) ZA98756B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287854B1 (en) 1996-10-22 2001-09-11 Imperial Cancer Research Technology Limited Diagnosis of susceptibility to cancer and treatment thereof
US6482795B1 (en) * 1997-01-30 2002-11-19 Myriad Genetics, Inc. Tumor suppressor designated TS10q23.3
AU6653698A (en) * 1997-02-07 1998-08-26 Trustees Of Columbia University In The City Of New York, The Use of the p-ten suppressor gene in diagnosis and treatment of cancer
US6861256B2 (en) 1997-05-15 2005-03-01 The General Hospital Corporation Therapeutic and diagnostic tools for impaired glucose tolerance conditions
US6225120B1 (en) 1997-05-15 2001-05-01 The General Hospital Corporation Therapeutic and diagnostic tools for impaired glucose tolerance conditions
WO1999002704A2 (en) * 1997-07-08 1999-01-21 Cold Spring Harbor Laboratory Dual specifically phosphatase and methods of use
JP4339506B2 (ja) * 1997-08-26 2009-10-07 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子
AU2002226028A1 (en) 2000-11-14 2002-05-27 Board Of Regents, Unversity Of Texas Systems Mutant human factor ix with an increased resistance to inhibition by heparin
AU2002359697A1 (en) * 2001-12-20 2003-07-09 Tularik Inc. Identification of an amplified gene and target for drug intervention
WO2005044091A2 (en) * 2003-11-05 2005-05-19 Board Of Regents, The University Of Texas System Diagnostic and therapeutic methods and compositions involving pten and breast cancer
CN103424541B (zh) 2006-05-18 2018-01-30 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
US8768629B2 (en) * 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
US8583380B2 (en) 2008-09-05 2013-11-12 Aueon, Inc. Methods for stratifying and annotating cancer drug treatment options
CN107254538A (zh) 2008-11-12 2017-10-17 卡里斯生命科学瑞士控股有限责任公司 使用外来体来确定表现型的方法和系统
KR20130056855A (ko) 2010-03-01 2013-05-30 카리스 라이프 사이언스 룩셈부르크 홀딩스 치료진단용 생물학적 지표들
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들
CN103228798B (zh) 2010-09-24 2015-12-09 斯坦福大学托管董事会 使用固定的引物直接捕获、扩增及测序靶标dna
BR112014013544A8 (pt) 2011-12-30 2017-06-13 Abbott Molecular Inc materiais e métodos para diagnose, prognose e avaliação do tratamento terapêutico/profilático de câncer da próstata

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
EP0273085A1 (en) 1986-12-29 1988-07-06 IntraCel Corporation A method for internalizing nucleic acids into eukaryotic cells
AU622104B2 (en) 1987-03-11 1992-04-02 Sangtec Molecular Diagnostics Ab Method of assaying of nucleic acids, a reagent combination and kit therefore
FR2616841A1 (fr) 1987-06-17 1988-12-23 Rauner Hans Perfectionnements au systeme de bloquage en position ouverte a levier de serrage pivotant, pour fiches et paumelles de portes et de fenetres
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
CA1323293C (en) 1987-12-11 1993-10-19 Keith C. Backman Assay using template-dependent nucleic acid probe reorganization
EP0359789B1 (en) 1988-01-21 1993-08-04 Genentech, Inc. Amplification and detection of nucleic acid sequences
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US4932207A (en) 1988-12-28 1990-06-12 Sundstrand Corporation Segmented seal plate for a turbine engine
US5279721A (en) 1993-04-22 1994-01-18 Peter Schmid Apparatus and method for an automated electrophoresis system
AU722266B2 (en) 1995-10-23 2000-07-27 Imperial Cancer Research Technology Limited Diagnosis of susceptibility to cancer and treatment thereof
JP4339506B2 (ja) * 1997-08-26 2009-10-07 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子
US8312249B1 (en) 2008-10-10 2012-11-13 Apple Inc. Dynamic trampoline and structured code generation in a signed code environment
FR2957821B1 (fr) 2010-03-24 2014-08-29 Inst Francais Du Petrole Nouvelle zone de regeneration du catalyseur divisee en secteurs pour unites catalytiques regeneratives

Similar Documents

Publication Publication Date Title
JP2009039107A5 (enExample)
JP2010259438A5 (enExample)
KR102361676B1 (ko) Snora14b를 포함하는 내성 암 진단용 바이오마커 조성물 및 이의 용도
CN103540657A (zh) 食道癌确定用组合物及方法
US8501419B2 (en) Exposed proliferation-related peptides, ligands and methods employing the same
CN115667304A (zh) 抗人lag-3抗体及其在免疫组织化学(ihc)中的用途
CN107188965A (zh) 抗dog1蛋白单克隆抗体及其用途
US20070264651A1 (en) Methods, compositions, and kits for the detection and monitoring of kidney cancer
US20080108070A1 (en) Methods, compositions, and kits for the detection and monitoring of colon cancer
JP3888695B2 (ja) ヒトｌｅｃｔ２に対する抗体、それを産生する細胞、その測定法及び測定用キット
KR20170124683A (ko) 담도암 진단용 신규 바이오마커로서의 융합 유전자 및 융합 단백질
JP2009535033A5 (enExample)
CN114316041B (zh) 一种NLS-RARα单克隆抗体的制备方法和一种基于该抗体的快速检测卡及其制备方法
CN1316435A (zh) 人睾丸发育特异性蛋白－8基因编码蛋白
CN101684499A (zh) 诊断和治疗与人转酮酶样-1基因过表达有关的增殖异常的组合物和方法
CN1382697A (zh) 人睾丸发育特异性蛋白－28基因编码蛋白
CN115561456A (zh) 体外定量b肝病毒大表面蛋白的套组以及用于处理肝病的生物指标组及单株抗体组
HK40080983A (en) Anti-human lag-3 antibodies and their use in immunohistochemistry (ihc)
CN121319199A (zh) 一种靶向ptgs1蛋白稳定新抗原表位的单克隆抗体及其应用
CN101300348A (zh) 肾癌诊断、肾癌患者预后预测用的组合物及方法
CN1318563A (zh) 人睾丸发育特异性蛋白－6基因编码蛋白
CN1313342A (zh) 人睾丸新型乳酸脱氢酶a基因编码蛋白
CN1318559A (zh) 人精子骨架蛋白基因编码蛋白
CN1313341A (zh) 人睾丸蛋白激酶基因编码蛋白
CN1318558A (zh) 人睾丸发育特异性蛋白－12基因编码蛋白